Kamada Ltd. (KMDA) Financials

KMDA Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 378.8 million 109.7 million
Sept. 30, 2025 377.2 million 112.0 million
June 30, 2025 368.2 million 108.2 million
March 31, 2025 375.1 million 123.1 million

KMDA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 5.0 million 458000
Sept. 30, 2025 6.8 million 117000
June 30, 2025 6.0 million 95000
March 31, 2025 -2.0 million 175000

KMDA Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 3.6 million
Sept. 30, 2025 5.3 million
June 30, 2025 7.4 million
March 31, 2025 4.0 million

KMDA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 75.5 million - 9.4 million
Sept. 30, 2025 72.0 million - 11.5 million
June 30, 2025 66.0 million - 11.4 million
March 31, 2025 76.3 million - 11.1 million

KMDA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 61.7 million
Sept. 30, 2025 58.8 million
June 30, 2025 56.7 million
March 31, 2025 56.6 million

KMDA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 2.9 million 3.0 million 10.7 million -
Sept. 30, 2025 3.6 million 2.6 million 9.3 million 4.5 million
June 30, 2025 2.0 million 3.2 million 8.6 million 4.6 million
March 31, 2025 1.5 million 4.2 million 8.7 million 4.5 million

KMDA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 45.6 million 28.3 million
Sept. 30, 2025 47.0 million 27.2 million
June 30, 2025 44.8 million 25.8 million
March 31, 2025 44.0 million 23.3 million

KMDA

Price: $7.28

52 week price:
6.50
9.35

Dividend Yield: 3.33%

5-year range yield:
2.72%
3.33%

Forward Dividend Yield: 3.43%

Payout Ratio Range:
6.61%
285.46%

Dividend Per Share: 0.25 USD

Earnings Per Share: 0.35 USD

P/E Ratio: 21.71

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Israel

Volume: 40400

Ebitda: 7.4 million

Market Capitalization: 432.7 million

Average Dividend Frequency: 1

Years Paying Dividends: 1

Links: